Elucidating the fundamental fibrotic processes driving abdominal adhesion formation

Deshka S. Foster(Stanford University), Clement D. Marshall(Stanford University), Gunsagar S. Gulati(Stanford University), Malini Chinta(Stanford University), Alan Nguyen(Stanford University), Ankit Salhotra(Stanford University), Ruth Ellen Jones(Stanford University), Austin Burcham(Stanford University), Tristan Lerbs(Stanford University), Lu Cui(Stanford University), Megan E. King(Stanford University), Ashley L. Titan(Stanford University), Ryan C. Ransom(Stanford University), Anoop Manjunath(Stanford University), Michael S. Hu(Stanford University), Charles P. Blackshear(Stanford University), Shamik Mascharak(Stanford University), Alessandra L. Moore(Stanford University), Jeffrey A. Norton(Stanford University), Cindy Kin(Stanford University), Andrew Shelton(Stanford University), Michael Januszyk(Stanford University), Geoffrey C. Gurtner(Stanford University), Gerlinde Wernig(California Institute for Regenerative Medicine), Michael T. Longaker(Institute for Stem Cell Biology and Regenerative Medicine)
Nature Communications
August 13, 2020
Cited by 115Open Access
Full Text

Abstract

Adhesions are fibrotic scars that form between abdominal organs following surgery or infection, and may cause bowel obstruction, chronic pain, or infertility. Our understanding of adhesion biology is limited, which explains the paucity of anti-adhesion treatments. Here we present a systematic analysis of mouse and human adhesion tissues. First, we show that adhesions derive primarily from the visceral peritoneum, consistent with our clinical experience that adhesions form primarily following laparotomy rather than laparoscopy. Second, adhesions are formed by poly-clonal proliferating tissue-resident fibroblasts. Third, using single cell RNA-sequencing, we identify heterogeneity among adhesion fibroblasts, which is more pronounced at early timepoints. Fourth, JUN promotes adhesion formation and results in upregulation of PDGFRA expression. With JUN suppression, adhesion formation is diminished. Our findings support JUN as a therapeutic target to prevent adhesions. An anti-JUN therapy that could be applied intra-operatively to prevent adhesion formation could dramatically improve the lives of surgical patients.


Related Papers

No related papers found

Powered by citation graph analysis